Skip to market wire
InvestLog
← Back to Stock Events← 返回个股快讯
PFERegulatory Decision监管决定Primary source一手来源Source link原始来源by InvestLog AIInvestLog AI 整理
Event time: 事件时间：
Published: 文章发布：

PFE receives FDA approval for as Front-Line Maintenance TreatmentPfizer Inc.（PFE）的 as Front-Line Maintenance Treatment 获美国 FDA 批准

PFE receives FDA approval for as Front-Line Maintenance Treatment.

Pfizer Inc.（PFE）的 as Front-Line Maintenance Treatment 获美国 FDA 批准。

View PFE stock details ->查看 PFE 个股详情 ->

For information only. Not investment advice.内容仅供参考，不构成投资建议。

Related articles相关阅读

Cantor Fitzgerald raises PFE target to $28Cantor Fitzgerald 上调目标价 辉瑞 (PFE) 至 $28

Rating Change · October 8, 2026评级变动 · 2026/10/8

Scotiabank raises PFE target to $33 from $30Scotiabank 上调目标价 辉瑞 (PFE)：$30 → $33

Rating Change · October 6, 2026评级变动 · 2026/10/6

HSBC raises PFE target to $30 from $28HSBC 上调目标价 辉瑞 (PFE)：$28 → $30

Rating Change · September 10, 2026评级变动 · 2026/9/10